




Searching News Database: Rhophylac
HSMN NewsFeed - 2 Apr 2007
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
Additional items found! 1

Members Archive contains
1 additional stories matching:
Rhophylac
(Password required)
Rhophylac
(Password required)